NCT04144985

Brief Summary

This study evaluated the discomfort associated with eyelid retraction during intravitreal injections. Participants had eyelid retraction with one of three methods: eyelid speculum, unimanual eyelid retraction method or with a cotton tipped applicator eyelid retraction technique. All participants were given a pain survey immediately after the injection to evaluate their discomfort level.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2018

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

October 17, 2019

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 30, 2019

Completed
Last Updated

October 30, 2019

Status Verified

October 1, 2019

Enrollment Period

6 months

First QC Date

October 17, 2019

Last Update Submit

October 28, 2019

Conditions

Keywords

DiscomfortVisual Analog ScaleSpeculumEyelid retractionCotton tipped applicatorEyelid SpeculumUnimanual eyelid retraction

Outcome Measures

Primary Outcomes (1)

  • Pain Associated with Different Eyelid Retraction Technique

    Within one minute of the injection, the participant was given a standard 100mm long visual analog scale (VAS) and asked to rate their pain from 0mm (no pain) to 100mm (the worst pain) regarding the process of the intravitreal injection.

    1 minute

Secondary Outcomes (2)

  • Difference in Pain in Treatment Naive Participants

    1 minute

  • Associations of Hemoglobin A1c and Ocular Pain

    1 minute

Study Arms (3)

Eyelid Speculum

ACTIVE COMPARATOR

Eyelid retraction was performed with an eyelid speculum.

Other: Visual analog scale (VAS) of pain to evaluate the discomfort participants experience.

Cotton Tipped Applicator

EXPERIMENTAL

Eyelid retraction was performed with the cotton tipped applicator eyelid retraction technique.

Other: Visual analog scale (VAS) of pain to evaluate the discomfort participants experience.

Unimanual Eyelid Retraction

EXPERIMENTAL

Eyelid retraction was performed with the unimanual eyelid retraction method.

Other: Visual analog scale (VAS) of pain to evaluate the discomfort participants experience.

Interventions

Eyelid retraction was performed with one of the three methods (eyelid speculum, unimanual eyelid retraction or cotton tipped applicator assisted eyelid retraction) and participants were then asked to rate their discomfort during the procedure with a visual analog scale (VAS) of pain.

Cotton Tipped ApplicatorEyelid SpeculumUnimanual Eyelid Retraction

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult participants receiving an intravitreal injection

You may not qualify if:

  • iodine allergy
  • prior ocular surgery other than uncomplicated cataract surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kings County Hospital

Brooklyn, New York, 11203, United States

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Joseph J Raevis, MD

    Kings County Hospital Department of Emergency Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Ophthalmology Resident

Study Record Dates

First Submitted

October 17, 2019

First Posted

October 30, 2019

Study Start

October 1, 2017

Primary Completion

March 31, 2018

Study Completion

March 31, 2018

Last Updated

October 30, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations